Page 2 - Nasdaq Cmpx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cmpx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cmpx Today - Breaking & Trending Today

Analyzing Compass Therapeutics (NASDAQ:CMPX) and Genenta Science (NASDAQ:GNTA)

Compass Therapeutics (NASDAQ:CMPX – Get Free Report) and Genenta Science (NASDAQ:GNTA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Analyst Recommendations This is a breakdown of […] ....

United States , Compass Therapeutics Inc , Compass Therapeutics , Get Free Report , Genenta Science , Given Compass Therapeutic , Compass Therapeutics Daily , Nasdaq Cmpx , Stock Comparison , Stock Analysis ,

Compass Therapeutics to Participate in Upcoming Investor

BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company. ....

United States , New York , Danna Gifford , Compass Therapeutics Inc , Annual Biopharma Conference , Annual Global Investment Conference , Fireside Chat , Compass Therapeutics , Nasdaq Cmpx , Compass Therapeutics , Immuno Oncology ,

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives $9.05 Consensus Price Target from Analysts

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) has been given an average rating of “Buy” by the seven ratings firms that are presently covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have updated their coverage on the stock in […] ....

Thomasj Schuetz , Squarepoint Ops , Geode Capital Management , Susquehanna International Group , Compass Therapeutics Inc , Compass Therapeutics , Get Rating , International Group , Street Group , Street Corp , Capital Management , Therapeutics Stock Down , Compass Therapeutics Daily , Nasdaq Cmpx ,

Compass Therapeutics to Participate in Upcoming Investor

BOSTON, June 01, 2023 (GLOBE NEWSWIRE) Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company. ....

New York , United States , Danna Gifford , Compass Therapeutics Inc , World Medical Innovation Forum , Medical Innovation Forum , Mass General Brigham Innovation , Biologic Revolution , Compass Therapeutics , Nasdaq Cmpx , Compass Therapeutics ,

Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Declines By 5.9%

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Rating) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,060,000 shares, a drop of 5.9% from the April 30th total of 2,190,000 shares. Approximately 3.1% of the company’s stock are sold short. Based […] ....

Thomasj Schuetz , Compass Therapeutics Company Profile , Monashee Investment Management , Jefferies Financial Group , Eventide Asset Management , Securities Exchange Commission , Vivo Capital , Compass Therapeutics Inc , Vanguard Group Inc , Compass Therapeutics , Get Rating , Financial Group , Exchange Commission , Asset Management , Investment Management , Vanguard Group , Compass Therapeutics Daily , Nasdaq Cmpx ,